logo

Bristol-Myers Squibb Co: Analyzing BMY Stock Trends

PNC Stock

In terms of market performance, Bristol-Myers Squibb Co had a fairly even. The highest value for the stock in the past year was $61.08 on 01/27/25, and the lowest value was recorded at $39.35 on 07/05/24.

52-week price history of BMY Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Bristol-Myers Squibb Co’s current trading price is -0.79% away from its 52-week high, while its distance from the 52-week low is 54.00%. The stock’s price range during this period has spanned from $39.35 to $61.08. In the Healthcare sector, the Bristol-Myers Squibb Co’s shares surpassed a trading volume of approximately 10.84 million for the day, which was noticeably lower compared to the average daily volume of 9.11.0 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Bristol-Myers Squibb Co (BMY) has experienced a quarterly rise of 14.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 122.91B and boasts a workforce of 34100 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 54.83, with a change in price of +10.65. Similarly, Bristol-Myers Squibb Co recorded 10,929,542 in trading volume during the last 100 days, posting a change of +21.32%.

Examining BMY’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 3.00. Similarly, the long-term debt-to-equity ratio is also 2.93.

BMY Stock Stochastic Average

Today, Bristol-Myers Squibb Co’s raw stochastic average for the past 50 days stands at 92.05%, indicating a rise from the raw stochastic average of the last 20 days, which was 92.05%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 94.40% and 84.71% respectively.

BMY Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 7.14%. However, over the past six months, we’ve seen a weaker performance of 33.86%. The price of BMY fallen by 5.24% over the last 30 days. And in the last five days, it has surged by 7.66%.

Most Popular